重庆医科大学学报
重慶醫科大學學報
중경의과대학학보
UNIVERSITATIS SCIENTIAE MEDICINAE CHONGQING
2009年
12期
1646-1650
,共5页
赵婷婷%邓华瑜%赵敬%杜佳%陈黎
趙婷婷%鄧華瑜%趙敬%杜佳%陳黎
조정정%산화유%조경%두가%진려
ErbB2非过表达乳腺癌细胞%AG825%神经调节因子%增殖
ErbB2非過錶達乳腺癌細胞%AG825%神經調節因子%增殖
ErbB2비과표체유선암세포%AG825%신경조절인자%증식
Non-overexpression ErbB2 breast cancer cell%AG825%Neuregulins%Proliferation
目的:探讨在ErbB2非过表达乳腺癌细胞中是否存在NRGs/ErbB2这种配体作用方式的信号通路活化,进而研究神经调节因子(Neuregulins'NRGs)对ErbB2受体信号转导活化和细胞增殖生长的作用.方法:以ErbB2非过表达乳腺癌细胞MDA-MB-231和MCF-7为研究对象,台盼蓝拒染法检测细胞生长曲线;免疫细胞化学法和Western blot法检测细胞中NRG的表达.应用ErbB2受体功能抑制剂AG825处理两株细胞,MTT法检测比较两株细胞的增殖抑制作用,求出AG825作用MDA-MB-231细胞48 h的IC_(50).40 μmol/L AG825处理MDA-MB-231细胞48 h,流式细胞术检测细胞周期和细胞凋亡.结果:与MCF-7细胞比较,MDA-MB-231细胞具有较强的增殖生长能力.NRG在MDA-MB-231细胞内呈显著表达,MCF-7细胞中无NRG的表达.Western blot实验检测MDA-MB-231细胞可见分子量44 kD的NRG抗体阳性反应条带.应用ErbB2受体功能抑制剂AG825后,MDA-MB-231细胞的增殖抑制作用明显,AG825作用MDA-MB-231细胞48 h的IC_(50)为56.59 μmol/L.40μmol/LAG825处理MDA-MB-231细胞48 h后,细胞周期阻滞在G_0G_1期(P<0.05);细胞凋亡增加(P<0.01).结论:ErbB2非过表达乳腺癌细胞MDA-MB-231可能通过NRGs自分泌或旁分泌作用方式使ErbB2受体信号转导处于激活状态,这与其高增殖、低凋亡恶性行为有关.
目的:探討在ErbB2非過錶達乳腺癌細胞中是否存在NRGs/ErbB2這種配體作用方式的信號通路活化,進而研究神經調節因子(Neuregulins'NRGs)對ErbB2受體信號轉導活化和細胞增殖生長的作用.方法:以ErbB2非過錶達乳腺癌細胞MDA-MB-231和MCF-7為研究對象,檯盼藍拒染法檢測細胞生長麯線;免疫細胞化學法和Western blot法檢測細胞中NRG的錶達.應用ErbB2受體功能抑製劑AG825處理兩株細胞,MTT法檢測比較兩株細胞的增殖抑製作用,求齣AG825作用MDA-MB-231細胞48 h的IC_(50).40 μmol/L AG825處理MDA-MB-231細胞48 h,流式細胞術檢測細胞週期和細胞凋亡.結果:與MCF-7細胞比較,MDA-MB-231細胞具有較彊的增殖生長能力.NRG在MDA-MB-231細胞內呈顯著錶達,MCF-7細胞中無NRG的錶達.Western blot實驗檢測MDA-MB-231細胞可見分子量44 kD的NRG抗體暘性反應條帶.應用ErbB2受體功能抑製劑AG825後,MDA-MB-231細胞的增殖抑製作用明顯,AG825作用MDA-MB-231細胞48 h的IC_(50)為56.59 μmol/L.40μmol/LAG825處理MDA-MB-231細胞48 h後,細胞週期阻滯在G_0G_1期(P<0.05);細胞凋亡增加(P<0.01).結論:ErbB2非過錶達乳腺癌細胞MDA-MB-231可能通過NRGs自分泌或徬分泌作用方式使ErbB2受體信號轉導處于激活狀態,這與其高增殖、低凋亡噁性行為有關.
목적:탐토재ErbB2비과표체유선암세포중시부존재NRGs/ErbB2저충배체작용방식적신호통로활화,진이연구신경조절인자(Neuregulins'NRGs)대ErbB2수체신호전도활화화세포증식생장적작용.방법:이ErbB2비과표체유선암세포MDA-MB-231화MCF-7위연구대상,태반람거염법검측세포생장곡선;면역세포화학법화Western blot법검측세포중NRG적표체.응용ErbB2수체공능억제제AG825처리량주세포,MTT법검측비교량주세포적증식억제작용,구출AG825작용MDA-MB-231세포48 h적IC_(50).40 μmol/L AG825처리MDA-MB-231세포48 h,류식세포술검측세포주기화세포조망.결과:여MCF-7세포비교,MDA-MB-231세포구유교강적증식생장능력.NRG재MDA-MB-231세포내정현저표체,MCF-7세포중무NRG적표체.Western blot실험검측MDA-MB-231세포가견분자량44 kD적NRG항체양성반응조대.응용ErbB2수체공능억제제AG825후,MDA-MB-231세포적증식억제작용명현,AG825작용MDA-MB-231세포48 h적IC_(50)위56.59 μmol/L.40μmol/LAG825처리MDA-MB-231세포48 h후,세포주기조체재G_0G_1기(P<0.05);세포조망증가(P<0.01).결론:ErbB2비과표체유선암세포MDA-MB-231가능통과NRGs자분비혹방분비작용방식사ErbB2수체신호전도처우격활상태,저여기고증식、저조망악성행위유관.
Objective:To explore whether there was activation of NRGs/ErbB2 ligand signal transduction pathway on non-overexpression ErbB2 breast cancer cell in order to investigate the effect of activation and proliferation of NRGs on ErbB2 receptor signal transduction pathway.Methods:Non-overexpression ErbB2 breast cancer cell MDA-MB-231 and MCF-7 were studied in the study.Growth curves of the two cell lines were obtained by the trypan blue exclusion method.The expressions of neuregnlin were detected by immunocytochemistry and Western blot.MDA-MB-231 cells and MCF-7 cells were treated with ErbB2 kinase inhibitor AG825,The effect of AG825 on the proliferation was investigated by MTT assay to compare the different effects between the two kinds of cells.The intermediate concentration IC_(50) in 48 hours in MDA-MB-231 cells was determined.MDA-MB-231 cells were treated with 40μmol/L AG825 for 48 hours,and the cell cycle and apoptosis were detected by flow cytometry.Results:Compared with MCF-7 cells,MDA-MB-231 cells presented strong growth ability.MDA-MB-231 cells expressed a relatively higher level of neuregulin,and MCF-7 cells did not express neuregnlin.In the Western blot,the positive reaction band was found in 44 kD which coincided with the molecular weight of NRG in MDA-MB-231 cells.When MDA-MB-231 cells and MCF-7 cells were treated with AG825,MDA-MB-231 cells were inhibited more obviously.The intermediate concentration IC_(50) of AG825 in MDA-MB-231 cells was 56.59 μmol/L.After MDA-MB-231 cells were treated with 40μmol/L AG825 for 48 hours,the cell cycle was arrested in G_0/G_1 phase(P<0.05),and the apoptosis rate was increased (P<0.01).Conclusion :Our study indicated in MDA-MB-231 cells neuregulins could activate ErbB2 receptor signal transduetion pathway by autocrine or paracrine action,which has relation to malignancy behavior of the cells with higher proliferation and lower apoptosis.